S&P 500   5,056.06 (-0.11%)
DOW   37,813.03 (+0.21%)
QQQ   430.58 (-0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
S&P 500   5,056.06 (-0.11%)
DOW   37,813.03 (+0.21%)
QQQ   430.58 (-0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
S&P 500   5,056.06 (-0.11%)
DOW   37,813.03 (+0.21%)
QQQ   430.58 (-0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
S&P 500   5,056.06 (-0.11%)
DOW   37,813.03 (+0.21%)
QQQ   430.58 (-0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
NYSE:LFCHY

China Life Insurance (LFCHY) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$6.21
$6.21
52-Week Range
N/A
Volume
74,500 shs
Average Volume
662,910 shs
Market Capitalization
$35.10 billion
P/E Ratio
4.40
Dividend Yield
6.71%
Price Target
N/A
LFCHY stock logo

About China Life Insurance Stock (NYSE:LFCHY)

China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses. It offers critical illness protection, annuity, children/women/pension, security, life, medical, and accident protection insurance products. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company Limited.

LFCHY Stock News Headlines

This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
See More Headlines
Receive LFCHY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Life Insurance and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Life insurance
Sub-Industry
N/A
Current Symbol
NYSE:LFCHY
Employees
1,613,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$127.86 billion
Book Value
$11.94 per share

Miscellaneous

Outstanding Shares
5,652,941,000
Free Float
N/A
Market Cap
$35.10 billion
Optionable
Optionable
Beta
0.59
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Ms. Hong Yang (Age 55)
    VP, Operating Director & GM of the Operation Service Center
    Comp: $205.29k
  • Ms. Di Zhang (Age 54)
    Assistant to the Pres & Chief Investment Officer
  • Mr. Ruan Qi (Age 56)
    VP
    Comp: $205.23k
  • Mr. Chongmiao Xu (Age 53)
    Compliance Officer, GM of the Legal & Compliance Department and Legal Officer
    Comp: $128.07k
  • Mr. Zhong Zhan (Age 54)
    VP, Marketing Director & GM of Individual Insurance Division
    Comp: $205.23k
  • Ms. Xiumei Huang (Age 55)
    VP & Exec. Director
    Comp: $205.52k
  • Mr. Mingguang Li (Age 53)
    Chief Actuary, VP, Board Sec. & Exec. Director
    Comp: $208.06k
  • Mr. Guodong Zhao (Age 55)
    Assistant to the Pres
    Comp: $122.27k
  • Mr. Yuejin Liu (Age 55)
    Assistant to the Pres
    Comp: $60.61k
  • Dr. Tao Bai Ph.D. (Age 59)
    Exec. Chairman

Should I Buy China Life Insurance Stock? LFCHY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in China Life Insurance Company Limited:

  • China Life Insurance Company Limited has a strong presence in the life insurance industry in China, a market with significant growth potential.
  • The company offers a diverse range of insurance products including critical illness protection, annuity, and medical insurance, catering to various customer needs.
  • Recent positive developments in the company's financial performance have shown promising growth prospects, indicating potential for increased shareholder value.
  • China Life Insurance Company Limited's stock price has been relatively stable and has shown resilience during market fluctuations, providing a sense of security to investors.
  • The company's strong brand reputation and long-standing history since its founding in 1949 reflect stability and trustworthiness in the market.

Cons

Investors should be bearish about investing in China Life Insurance Company Limited for these reasons:

  • The competitive landscape in the insurance industry in China is intense, leading to potential pricing pressures and challenges in market share growth.
  • Regulatory changes in the insurance sector in China could impact the company's operations and profitability, introducing uncertainties for investors.
  • China Life Insurance Company Limited's dividend score and overall financial metrics have not shown significant improvement recently, raising concerns about returns for investors.
  • The company's valuation score and sustainability score have remained stagnant, indicating limited upside potential for investors in the near term.
  • Market sentiment and short interest scores for China Life Insurance Company Limited have been neutral, suggesting a lack of significant positive catalysts for stock price appreciation.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, April 12, 2024. Please send any questions or comments about these China Life Insurance pros and cons to contact@marketbeat.com.

LFCHY Stock Analysis - Frequently Asked Questions

Is China Life Insurance a good dividend stock?

China Life Insurance (NYSE:LFCHY) pays an annual dividend of $0.41 per share and currently has a dividend yield of 6.71%. LFCHY has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 32.80%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, LFCHY will have a dividend payout ratio of 29.50% next year. This indicates that the company will be able to sustain or increase its dividend.

This page (NYSE:LFCHY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners